Cradle

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

Grok-1.5 Vision (Grok-1.5V) is a groundbreaking multimodal AI model developed by Elon Musk's research lab, x.AI. This advanced model has the potential to revolutionize the field of artificial intelligence and shape the future of various industries. Grok-1.5V combines the capabilities of computer vision, natural language processing, and other AI techniques to provide a comprehensive understanding of the world around us. With its ability to analyze and interpret visual data, Grok-1.5V can assist in tasks such as object recognition, image classification, and scene understanding. Additionally, its natural language processing capabilities enable it to comprehend and generate human language, making it a powerful tool for communication and information retrieval. Grok-1.5V's multimodal nature sets it apart from traditional AI models, allowing it to handle complex tasks that require a combination of visual and linguistic understanding. This makes it a valuable asset for applications in fields such as healthcare, manufacturing, and customer service.

Wild Moose is an AI-powered SRE Copilot tool designed to help companies handle incidents efficiently. It offers fast and efficient root cause analysis that improves with every incident by automatically gathering and analyzing logs, metrics, and code to pinpoint root causes. The tool converts tribal knowledge into custom playbooks, constantly improves performance with a system model that learns from each incident, and integrates seamlessly with various observability tools and deployment platforms. Wild Moose reduces cognitive load on teams, automates routine tasks, and provides actionable insights in real-time, enabling teams to act fast during outages.

Variational AI is a company that uses generative AI to discover novel drug-like small molecules with optimized properties for defined targets. Their platform, Enki™, is the first commercially accessible foundation model for small molecules. It is designed to make generating novel molecule structures easy, with no data required. Users simply define their target product profile (TPP) and Enki does the rest. Enki is an ensemble of generative algorithms trained on decades worth of experimental data with proven results. The company was founded in September 2019 and is based in Vancouver, BC, Canada.

Camel AGI is a groundbreaking platform that revolutionizes the way artificial intelligence is utilized to solve complex tasks by employing a unique role-playing method inspired by loop architecture, similar to that of BabyAGI and AutoGPT. At its core, CamelAGI facilitates the collaboration between two autonomous AI agents, each assigned specific roles, to work synergistically towards accomplishing a designated task. This innovative approach allows users to observe as the agents, equipped with distinct capabilities and perspectives, engage in a dynamic and context-aware dialogue, effectively mirroring the collaborative efforts seen in human interactions.

Bash Senpai is a terminal assistant powered by ChatGPT that transforms instructions into ready-to-use commands. It provides convenience by allowing users to get answers without leaving the terminal and offers better answers by providing context with questions. The tool also incorporates self-reflection to improve the quality of its responses.

Clearbit is a B2B marketing intelligence platform that provides data enrichment, scoring, routing, and buying intent signals. It is powered by artificial intelligence and is the first HubSpot Native Data Provider. Clearbit's data foundation is built on public data from the web, proprietary data, and the power of LLMs to convert unstructured information into precise and standardized data sets. This data can be used to enrich leads, contacts, and accounts, and to identify hidden buying intent. Clearbit also offers a variety of features to help businesses score and route leads, and to create better converting forms.

Stately is a visual logic builder that enables users to create complex logic diagrams and code in minutes. It provides a drag-and-drop editor that brings together contributors of all backgrounds, allowing them to collaborate on code, diagrams, documentation, and test generation in one place. Stately also integrates with AI to assist in each phase of the development process, from scaffolding behavior and suggesting variants to turning up edge cases and even writing code. Additionally, Stately offers bidirectional updates between code and visualization, allowing users to use the tools that make them most productive. It also provides integrations with popular frameworks such as React, Vue, and Svelte, and supports event-driven programming, state machines, statecharts, and the actor model for handling even the most complex logic in predictable, robust, and visual ways.

Mixpeek is a multimodal intelligence platform that helps users extract important data from videos, images, audio, and documents. It enables users to focus on insights rather than data preparation by identifying concepts, activities, and objects from various sources. Mixpeek offers features such as real-time synchronization, extraction and embedding, fine-tuning and scaling of models, and seamless integration with various data sources. The platform is designed to be easy to use, scalable, and secure, making it suitable for a wide range of applications.

Kira Systems is a machine learning contract search, review, and analysis software that helps businesses identify, extract, and analyze content in their contracts and documents. It uses patented machine learning technology to extract concepts and data points with high efficiency and accuracy. Kira also has built-in intelligence that streamlines the contract review process with out-of-the-box smart fields. Businesses can also create their own smart fields to find specific data points using Kira's no-code machine learning tool. Kira's adaptive workflows allow businesses to organize, track, and export results. Kira has a partner ecosystem that allows businesses to transform how teams work with their contracts.

Tavily is an AI-powered research assistant that helps users gather information from multiple online sources and organize it into comprehensive research reports. It uses advanced algorithms and models to ensure the accuracy of the information provided and can be integrated with any LLM. Tavily is suitable for both individuals and enterprises who need to conduct research to make unbiased and informed decisions.

Quadratic is an infinite spreadsheet with Python, SQL, and AI. It combines the familiarity of a spreadsheet with the power of code, allowing users to analyze data, write code, and create visualizations in a single environment. With built-in Python library support, users can bring open source tools directly to their spreadsheets. Quadratic also features real-time collaboration, allowing multiple users to work on the same spreadsheet simultaneously. Additionally, Quadratic is built for speed and performance, utilizing Web Assembly and WebGL to deliver a smooth and responsive experience.

Sonify is a company that specializes in the intersection of audio, data, and emerging technologies. They design and develop audio-first products and data-driven solutions. Sonify's mission is to make data more accessible and understandable through the use of sound. They believe that sound is a powerful tool that can be used to communicate complex information in a way that is both engaging and informative.

Vidrovr is a video analysis platform that uses machine learning to process unstructured video, image, or audio data. It provides business insights to help drive revenue, make strategic decisions, and automate monotonous processes within a business. Vidrovr's technology can be used to minimize equipment downtime, proactively plan for equipment replacement, leverage AI to empower mission objectives and decision making, monitor persons or topics of interest across various media sources, ensure critical infrastructure is monitored 24/7/365, and protect ecological assets.

Mintlify is a modern documentation platform that helps businesses create beautiful, engaging, and user-friendly documentation. It is designed to be easy to use and maintain, and it offers a variety of features to help businesses improve their user engagement and conversions. Mintlify is used by a variety of companies, from fast-growing startups to large enterprises.

Fillout is an AI-powered form builder that allows users to create powerful forms, surveys, and quizzes that their audience will enjoy answering. It is designed to be easy to use, with a drag-and-drop interface and a variety of templates to choose from. Fillout also integrates with a variety of other tools, such as Airtable, Salesforce, and Google Sheets, making it a versatile option for businesses of all sizes.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that helps in drug development by providing accurate predictions for small molecule drugs. The application utilizes AI technology to optimize solid-state formulations, reduce turnaround time, mitigate risks, and discover novel polymorphs, ultimately streamlining the pharmaceutical research and development process.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

C&EN, a publication of the American Chemical Society, provides the latest news and insights on the chemical industry, including research, technology, business, and policy. It covers a wide range of topics, including analytical chemistry, biological chemistry, business, careers, education, energy, environment, food, materials, people, pharmaceuticals, physical chemistry, policy, research integrity, safety, and synthesis.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

Cerebras is an AI tool that offers products and services related to AI supercomputers, cloud system processors, and applications for various industries. It provides high-performance computing solutions, including large language models, and caters to sectors such as health, energy, government, scientific computing, and financial services. Cerebras specializes in AI model services, offering state-of-the-art models and training services for tasks like multi-lingual chatbots and DNA sequence prediction. The platform also features the Cerebras Model Zoo, an open-source repository of AI models for developers and researchers.

CCDS (Center for Computational & Data Sciences) is a research center at Independent University Bangladesh dedicated to artificial intelligence, data sciences, and computational science. The center has various wings focusing on AI, computational biology, physics, data science, human-computer interaction, and industry partnerships. CCDS explores the use of computation to understand nature and society, uncover hidden stories in data, and tackle complex challenges. The center collaborates with institutions like CERN and the Dunlap Institute for Astronomy and Astrophysics.